Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure
Angel R. León(Emory Healthcare), Kevin R. Wheelan(Baylor University Medical Center), James P. Daubert(Johns Hopkins University), Anne B. Curtis(University at Buffalo, State University of New York), William T. Abraham(The Ohio State University), Westby G. Fisher(Northwestern University), David L. Hayes(Computer Technology Associates (United States)), John C. Gurley(University of Kentucky), Randy Lieberman(Harper University Hospital), Susan Petersen‐Stejskal(Medtronic (United States))
Cited by 250
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria
|European Heart Journal|2010|1.6k